Dendreon Pharmaceuticals LLC expanded senior management with three hires and two promotions after returning its headquarters to Orange County this summer following a sale.
Chris Carr, a veteran of Abbott Laboratories, joined as chief financial officer. Christina Yi was promoted to chief operations officer and Matt Kemp to chief commercial officer. Kevin Helmbacher joins as general counsel and senior vice president of legal and compliance, and Beth Mueller as senior vice president of human resources. The biopharmaceutical company has added 60 employees companywide since it relocated from Bridgewater, N.J. to Seal Beach in June.
The move came after former owner Valeant Pharmaceuticals International Inc. sold Dendreon to privately held Sanpower Group Co. Ltd. in Najing, China, for nearly $820 million.
Dendreon had filed for bankruptcy and was acquired by Valeant in 2015.
The company sells Provenge, an immunotherapy for men with advanced prostate cancer that the Food and Drug Administration approved in 2010.
— Sherry Hsieh
